Sign In
Buy TMCI
$4.31
-0.0700 (-1.60%)
At Close: Jul 31, 2026
Treace to Report First Quarter 2023 Financial Results on May 8, 2023
04:15pm, Thursday, 20'th Apr 2023
PONTE VEDRA, Fla., April 20, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment
Treace Medical Concepts (TMCI) Surges 7.6%: Is This an Indication of Further Gains?
09:09am, Monday, 10'th Apr 2023
Treace Medical Concepts (TMCI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in th
Why Treace Medical Concepts' Shares Rose Wednesday
03:50pm, Wednesday, 08'th Mar 2023
Treace Medical focuses on medical equipment therapies to treat bunions. The company released fourth-quarter and full-year earnings after the markets closed on Tuesday.
Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
04:15pm, Monday, 27'th Feb 2023
PONTE VEDRA, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment o
Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
04:15pm, Tuesday, 20'th Dec 2022
PONTE VEDRA, Fla., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Recent Price Trend in Treace Medical Concepts (TMCI) is Your Friend, Here's Why
10:32am, Monday, 19'th Dec 2022
Treace Medical Concepts (TMCI) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made
Treace Medical: Differentiated Offering In Lapiplasty Procedure, Rate Buy
05:52pm, Monday, 05'th Dec 2022
Treace Medical Concepts, Inc. has a key differentiator in its Lapiplasty procedure, with the potential to create a remedial breakthrough. The company showed strong top-line growth in Q3, reaffirming g
Treace Medical Concepts (TMCI) is on the Move, Here's Why the Trend Could be Sustainable
10:32am, Thursday, 01'st Dec 2022
Treace Medical Concepts (TMCI) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Treace Medical Concepts, Inc. (TMCI) Q3 2022 Earnings Call Transcript
02:16pm, Saturday, 12'th Nov 2022
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Vivian Cervantes - Investor Relations, Gilmartin Group John Treace - Chie
Treace Announces Participation in Upcoming Investor Conferences
04:15pm, Tuesday, 25'th Oct 2022
PONTE VEDRA, Fla., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment o
Treace to Report Third Quarter 2022 Financial Results on November 8, 2022
04:15pm, Tuesday, 18'th Oct 2022
PONTE VEDRA, Fla., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment o
Strength Seen in Treace Medical Concepts (TMCI): Can Its 8.4% Jump Turn into More Strength?
12:02pm, Monday, 12'th Sep 2022
Treace Medical Concepts (TMCI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in th
Treace Announces Participation in the Morgan Stanley 20th Annual Global Healthcare Conference
04:15pm, Wednesday, 24'th Aug 2022
PONTE VEDRA, Fla., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment o
Treace Medical Concepts, Inc. (TMCI) CEO John Treace on Q2 2022 Results - Earnings Call Transcript
12:10pm, Saturday, 13'th Aug 2022
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q2 2022 Results Conference Call August 9, 2022 4:30 PM ET Company Participants Vivian Cervantes - Investor Relations John Treace - Chief Executive Officer
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates
08:19pm, Tuesday, 09'th Aug 2022
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of -9.52% and 4.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
